Cipher Pharmaceuticals Inc.
CPHRF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $282 | $238 | $228 | $256 |
| - Cash | $8 | $11 | $22 | $18 |
| + Debt | $13 | $25 | $41 | $41 |
| Enterprise Value | $287 | $252 | $246 | $279 |
| Revenue | $13 | $13 | $12 | $12 |
| % Growth | -4.1% | 11.3% | 1.7% | – |
| Gross Profit | $10 | $11 | $9 | $7 |
| % Margin | 81.7% | 81.3% | 76% | 56.6% |
| EBITDA | $7 | $7 | $4 | $2 |
| % Margin | 52.8% | 50.8% | 35.7% | 14.1% |
| Net Income | $6 | $6 | $3 | $3 |
| % Margin | 42.9% | 44% | 21.8% | 28.3% |
| EPS Diluted | 0.21 | 0.22 | 0.1 | 0.13 |
| % Growth | -4.5% | 120% | -23.1% | – |
| Operating Cash Flow | $11 | $6 | $4 | $9 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | $11 | $6 | $4 | $9 |